Alcohol Use Disorder Treatment Market - Forecasts From 2019 To 2024

111 pages
Published on : May 2019
Report Code : KSI061612285


The alcohol use disorder treatment market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. The growing demand for the alcohol use disorder treatment is mainly attributed to the prevalence of this disease worldwide, with high prevalence reported in Eastern European countries, parts of South East Asia and selected countries in Americas. The prevalence of Fetal Alcohol Syndrome (FAS) in the United States was estimated by the Institute of Medicine in 1996 to be between 0.5 and 3.0 cases per 1,000. More recent reports from specific U.S. sites report the prevalence of FAS to be 2 to 7 cases per 1,000, and the prevalence of Fetal Alcohol Spectrum Disorders (FASD) to be as high as 20 to 50 cases per 1,000 (Source: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health). Furthermore, the rising number of deaths occurring due to the alcohol-related liver disease is driving the market growth during the forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the alcohol use disorder treatment value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the alcohol use disorder treatment market.

Major industry players profiled as part of the report are Teva Pharmaceuticals USA, Inc., Adial Pharmaceuticals, Alkermes, ADDEX THERAPEUTICS, and Kinnov Therapeutics among others.


The alcohol use disorder treatment market has been analyzed through following segments:

By Type

Alcohol Abuse

Alcoholism (Alcohol dependence)


By Treatment


Behavioural Therapies


By Geography

North America






South America








United Kingdom




Middle East and Africa

Saudi Arabia




Asia Pacific



South Korea




Target audience




Service Providers

Government Agencies

Research Organizations


Key insights offered

What will be the alcohol use disorder treatment market size from 2017 to 2023?

How are the major drivers and restraints affecting the alcohol use disorder treatment market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.